This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.
Standard submission dates apply for all listings, unless otherwise noted.
Guidance For Investigators Planning to Submit a Program Project Grant (P01)
Notice: Internet links not permitted in NIH Grant Applications
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
| Title | Announcement # | Expiration Date | Research Focus |
|---|---|---|---|
| Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed) | PA-20-227 | 04/16/2023 |
|
| Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research | PA-18-876 (R01 Clinical Trial Not Allowed) | 09/08/2021 |
|
| Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research | PA-18-902 (R01 Clinical Trial Optional) | 09/08/2021 |
|
| Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention | PAR-19-252 (R21 Clinical Trial Optional) | 11/09/2021 |
|
| Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention | PAR-19-251 (R01 Clinical Trial Optional) | 11/09/2021 |
|
| Biology of Bladder Cancer | PAR-19-184 (R21 Clinical Trial Optional) | 05/08/2022 |
|
| Biology of Bladder Cancer | PAR-19-183 (R01 Clinical Trial Optional) | 05/08/2022 |
|
| Cancer Prevention and Control Clinical Trials Grant Program | PAR-21-035 (R01 Clinical Trial Required) | 01/08/2024 |
|
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers | RFA-CA-21-038 (U54 Clinical Trial Not Allowed) | 10/08/2021 |
|
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) | RFA-CA-21-039 (U24 Clinical Trial Not Allowed) | 10/08/2021 |
|
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research | PAR-19-113 (R01 Clinical Trial Optional) | 01/08/2022 |
|
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies | PAR-19-325 (R01 Clinical Trial Optional) | 02/12/2022 |
|
| Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment | PA-18-917 (R01 - Clinical Trial Optional) | 09/08/2021 |
|
| Diet and Physical Activity Assessment Methodology | PAR-18-857 (R21 Clinical Trial Not Allowed) | 09/08/2021 |
|
| Diet and Physical Activity Assessment Methodology | PA-18-856 (R01 Clinical Trial Not Allowed) | 09/08/2021 |
|
| Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer | PAR-19-264 (R01 Clinical Trial Optional) | 12/11/2021 |
|
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | PA-19-112 (R01 Clinical Trial Optional) | 01/08/2022 |
|
| Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | PA-19-111 (R21 Clinical Trial Optional) | 01/08/2022 |
|
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain | PA-19-201 (R21 Clinical Trial Optional) | 05/08/2022 |
|
| Mechanisms Underlying the Contribution of Sleep Disturbances to Pain | PA-19-200 (R01 Clinical Trial Optional) | 05/08/2022 |
|
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer | PAR-19-199 (R21 Clinical Trial Not Allowed) | 11/09/2021 |
|
| Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer | PAR-19-198 (R01 Clinical Trial Not Allowed) | 11/09/2021 |
|
| Music and Health: Understanding And Developing Music Medicine | PAR-21-100 (R01 Clinical Trial Optional) | 02/06/2023 |
|
| Music and Health: Understanding And Developing Music Medicine | PAR-21-099 (R21 Clinical Trial Optional) | 02/17/2023 |
|
| NCI Clinical and Translational Exploratory/Developmental Studies | PAR-20-292 (R21 Clinical Trial Optional) | 07/21/2022 |
|
| Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | NOT-CA-20-067 (R01 Clinical Trial Not Allowed) | 01/08/2023 |
|
| Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers | NOT-CA-21-079 (U54 Clinical Trial Not Allowed) | 10/01/2021 |
|
| Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (DRCC) | NOT-CA-21-080 (U24 Clinical Trial Not Allowed) | 10/01/2021 |
|
| Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery | NOT-CA-21-091 (R21 Clinical Trial Not Allowed) | 11/01/2021 |
|
| Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms that Impact Cancer Risk after Bariatric Surgery | NOT-CA-21-090 (R01 Clinical Trial Optional) | 11/01/2021 |
|
| Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) | NOT-CA-20-031 | 01/08/2022 |
|
| Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers | NOT-CA-21-028 | 01/08/2024 |
|
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | 05/08/2023 |
|
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-893 (R01 Clinical Trial Optional) | 09/08/2021 |
|
| Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival | PAR-18-892 (R21 Clinical Trial Optional) | 09/08/2021 |
|
| Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | PAR-20-053 (R01 Clinical Trial Not Allowed) | 01/08/2023 |
|
| Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) | PAR-20-266 | 06/20/2023 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-277 (R21 Clinical Trials Not Allowed) | 09/08/2022 |
|
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-276 (R01 Clinical Trial Not Allowed) | 09/08/2022 |
|
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-038 (R01 Clinical Trial Not Allowed) | 12/29/2023 |
|
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-039 (R01 Basic Experimental Studies with Humans Required) | 12/29/2023 |
|
| The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) | RFA-CA-21-035 | 09/10/2021 |
|
| The Early Detection Research Network: Clinical Validation Centers | RFA-CA-21-033 (U01 Clinical Trial Optional) | 09/10/2021 |
|
| The Early Detection Research Network: Data Management and Coordinating Center | RFA-CA-21-034 (U24 Clinical Trial Not Allowed) | 09/10/2021 |
|
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research | PAR-18-913 (U01 Clinical Trial Not Allowed) | 08/12/2021 |
|
| Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) | PA-20-252 | 04/16/2022 |
|